BioCentury
ARTICLE | Clinical News

ARG201 regulatory update

February 23, 2009 8:00 AM UTC

EMEA granted Orphan Drug designation for arGentis' ARG201 to treat diffuse systemic sclerosis. The type I native bovine collagen, which also has Orphan designation in the U.S., has completed a Phase ...